Sarepta Therapeutics
The Associate Director, Nonclinical Safety will lead development of the nonclinical safety strategy for Sarepta’s therapeutic programs across research and clinical stages. This role is part of the Research Strategy & Operations team and partners with R&D to align nonclinical development with regulatory expectations and company priorities.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
We are focused on the development of precision genetic medicines to treat rare neuromuscular and central nervous system diseases. Learn more about Sarepta.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sarepta Therapeutics.
Sarepta Therapeutics CEO Doug Ingram will retire after a tumultuous decade
2 weeks ago
Associate Director, Toxicology, Nonclinical Development (Program Toxicologist)
8a7882525b6027b0015b692822e001ab
Associate Director, Nonclinical Development
ardelyx
Nonclinical Safety Lead
BioLife Plasma Services
Nonclinical Safety and Pathobiology Group Leader
Gilead Sciences
Director, Nonclinical Operations
GondolaBio ServiceCo
Associate Director / Director, Nonclinical Toxicology
Treeline Biosciences